International association for the study of lung cancer (IASLC) pathology committee group provided updates on the indications of ICIs for lung cancer in 2019 and discussed important considerations on pre-analytical, analytical, and post-analytical aspects of PD-L1 IHC testing [64]. This evidence concerns the gene CD274 and lung cancer.